|
WO2013155528A2
|
|
Methods for reducing brain inflammation, increasing insulin sensitivity, and reducing ceramide levels
|
|
CA2729767A1
|
|
Novel compounds, pharmaceutical compositions containing same, methods of use for same, and methods for preparing same
|
|
WO2009064927A2
|
|
Phosphorylated fatty acid synthase and cancer
|
|
EP1991213A2
|
|
Anti-mycobacterial formulation comprising octanesulphonylacetamide (osa), nonanesulphonylacetamide (nsa) and decanesulphonylacetamide (dsa)
|
|
WO2007014249A2
|
|
Novel compounds, pharmaceutical compositions containing same, and methods of use for same
|
